123 related articles for article (PubMed ID: 7556108)
21. Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa.
Chen T; Aidoo A; Mittelstaedt RA; Casciano DA; Heflich RH
Carcinogenesis; 1999 Feb; 20(2):269-77. PubMed ID: 10069464
[TBL] [Abstract][Full Text] [Related]
22. Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy.
Sawada M; Kubota M; Lin YW; Watanabe K; Koishi S; Usami I; Akiyama Y; Matsumura T; Furusho K
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):711-7. PubMed ID: 9718224
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
24. Acetaldehyde-induced mutation at the hprt locus in human lymphocytes in vitro.
He SM; Lambert B
Environ Mol Mutagen; 1990; 16(2):57-63. PubMed ID: 2209564
[TBL] [Abstract][Full Text] [Related]
25. Multiplex polymerase chain reaction-based analysis of T-cell receptor gamma gene rearrangements for the determination of T-lymphocyte clonality.
Ma H; Smith DH; Hsie AW; Ward JB
Environ Mol Mutagen; 2000; 35(1):1-8. PubMed ID: 10692221
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of hprt mutants induced by 2-cyanoethylene oxide in human lymphoblastoid cells.
Recio L; Simpson D; Cochrane J; Liber H; Skopek TR
Mutat Res; 1990 Nov; 242(3):195-208. PubMed ID: 2270092
[TBL] [Abstract][Full Text] [Related]
27. Determination of hprt mutant and mutation frequencies and the molecular characterization of human derived in vivo T-lymphocyte mutants.
Curry J; Rowley GT; Saddi V; Beare D; Cole J; Glickman BW
Environ Mol Mutagen; 1995; 25(3):167-79. PubMed ID: 7737134
[TBL] [Abstract][Full Text] [Related]
28. Elevated in vivo frequencies of mutant T cells with altered functional expression of the T-cell receptor or hypoxanthine phosphoribosyltransferase genes in p53-deficient mice.
Suzuki T; Kusunoki Y; Tsuyama N; Ohnishi H; Seyama T; Kyoizumi S
Mutat Res; 2001 Nov; 483(1-2):13-7. PubMed ID: 11600127
[TBL] [Abstract][Full Text] [Related]
29. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.
Albertini MR; King DM; Newton MA; Vacek PM
Mutat Res; 2001 May; 476(1-2):83-97. PubMed ID: 11336986
[TBL] [Abstract][Full Text] [Related]
30. A new T-lymphocyte cloning assay for detection of in vivo mutations in the human hypoxanthine-guanine phosphoribosyltransferase gene.
Uematsu K; Yasuda J; Sekine T; Sugano K; Kudoh S; Sekiya T
Environ Mol Mutagen; 1997; 30(1):31-9. PubMed ID: 9258327
[TBL] [Abstract][Full Text] [Related]
31. Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis.
Abramson LS; Albertini RJ; Pachman LM; Finette BA
Clin Immunol; 1999 Apr; 91(1):61-7. PubMed ID: 10219255
[TBL] [Abstract][Full Text] [Related]
32. HPRT mutations in vivo in human CD 34+ hematopoietic stem cells.
Grant BW; Trombley LM; Hunter TC; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1999 Dec; 431(2):183-98. PubMed ID: 10635986
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of in vivo hprt mutations in T lymphocytes from atomic bomb survivors. I. Sequence alterations in cDNA.
Shimahara H; Kato T; Hirai Y; Akiyama M
Carcinogenesis; 1995 Mar; 16(3):583-91. PubMed ID: 7697817
[TBL] [Abstract][Full Text] [Related]
34. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
[TBL] [Abstract][Full Text] [Related]
35. In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytes.
Nicklas JA; O'Neill JP; Hunter TC; Falta MT; Lippert MJ; Jacobson-Kram D; Williams JR; Albertini RJ
Mutat Res; 1991; 250(1-2):383-96. PubMed ID: 1944353
[TBL] [Abstract][Full Text] [Related]
36. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus.
Walker VE; Skopek TR
Mutat Res; 1993 Jul; 288(1):151-62. PubMed ID: 7686258
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of point mutations in the coding region of the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene in human T-lymphocytes in vivo.
Podlutsky A; Osterholm AM; Hou SM; Hofmaier A; Lambert B
Carcinogenesis; 1998 Apr; 19(4):557-66. PubMed ID: 9600338
[TBL] [Abstract][Full Text] [Related]
38. Genetic instability in human T-lymphocytes.
Albertini RJ; Nicklas JA; Skopek TR; Recio L; O'Neill JP
Mutat Res; 1998 May; 400(1-2):381-9. PubMed ID: 9685698
[TBL] [Abstract][Full Text] [Related]
39. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
40. Analysis of mutational effects at the HPRT locus in human G(0) phase lymphocytes irradiated in vitro with gamma rays.
Mognato M; Ferraro P; Canova S; Sordi G; Russo A; Cherubini R; Celotti L
Mutat Res; 2001 Mar; 474(1-2):147-58. PubMed ID: 11239972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
